Loading…
Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies
•New series of pyrazoline-amide linked 1,2,3-triazole hybrids was synthesized.•Pyrazoline-amide linked 1,2,3-triazole hybrid exhibited better antimicrobial activity compared to their precursors.•Docking studies were performed with E. coli Gyr A and A. Niger 14-α-demethylase.•The binding potential of...
Saved in:
Published in: | Journal of molecular structure 2021-12, Vol.1246, p.131154, Article 131154 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133 |
---|---|
cites | cdi_FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133 |
container_end_page | |
container_issue | |
container_start_page | 131154 |
container_title | Journal of molecular structure |
container_volume | 1246 |
creator | Kumar, Lokesh Lal, Kashmiri Kumar, Ashwani Paul, Avijit Kumar Kumar, Anil |
description | •New series of pyrazoline-amide linked 1,2,3-triazole hybrids was synthesized.•Pyrazoline-amide linked 1,2,3-triazole hybrid exhibited better antimicrobial activity compared to their precursors.•Docking studies were performed with E. coli Gyr A and A. Niger 14-α-demethylase.•The binding potential of 6e with both the target using molecular dynamics simulations was also studied.
A new series of pyrazoline-amide linked 1,2,3-triazole hybrids was wisely designed and synthesized using 1,3-dipolar cycloaddition between pyrazoline linked alkynes and 2-bromo-N-arylacetamide. All the newly synthesized compounds were evaluated in vitro against different microbial strains viz. Escherichia coli, Bacillius subtilis, Staphylococcus aureus, Aspergillus niger, and Candida albicans. Pyrazoline linked terminal alkynes (4a–c) showed MIC = 0.062–0.078 μmol/mL against different bacterial and fungal strain. However, pyrazoline-amide linked 1,2,3-triazole hybrids (6a-6t) showed MIC = 0.0229–0.050 μmol/mL. Compound 6e exhibited better efficacy against E. coli and both the fungal strains compared to standard drugs used. Docking studies of the most potent compounds were carried out against bacterial DNA Gyr A and fungal 14α-steroldemethylase were also performed. The binding potential of 4a and 6e with both the target using molecular dynamics simulations was also investigated.
[Display omitted] |
doi_str_mv | 10.1016/j.molstruc.2021.131154 |
format | article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_molstruc_2021_131154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022286021012849</els_id><sourcerecordid>S0022286021012849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133</originalsourceid><addsrcrecordid>eNqFkM1KAzEUhYMoWKuvIHmAznhzk5lJXSnFPygoqFtDmqR4y3RGkrRQn94p1bWrs_g4h8PH2KWAUoCor1blum9TjhtXIqAohRSiUkdsJHSDhQahjtkIALFAXcMpO0tpBQBiKI_Yx8su2u--pS7wHPJniMFzMcGJLHKkPQnpmr_uugElShNuu0xrcrFfkG152Np2YzP13QA8p44nasn1POWNp5DO2cnStilc_OaYvd_fvc0ei_nzw9Psdl44KTAXONVQY-N8rVAG3yiFta5Ao27kFHABEpdCYeV17UEvg1ausg5BNVbgQkg5ZvVhdziWUgxL8xVpbePOCDB7S2Zl_iyZvSVzsDQUbw7FMLzbUogmOQqdC55icNn4nv6b-AEM33Oz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies</title><source>ScienceDirect Freedom Collection</source><creator>Kumar, Lokesh ; Lal, Kashmiri ; Kumar, Ashwani ; Paul, Avijit Kumar ; Kumar, Anil</creator><creatorcontrib>Kumar, Lokesh ; Lal, Kashmiri ; Kumar, Ashwani ; Paul, Avijit Kumar ; Kumar, Anil</creatorcontrib><description>•New series of pyrazoline-amide linked 1,2,3-triazole hybrids was synthesized.•Pyrazoline-amide linked 1,2,3-triazole hybrid exhibited better antimicrobial activity compared to their precursors.•Docking studies were performed with E. coli Gyr A and A. Niger 14-α-demethylase.•The binding potential of 6e with both the target using molecular dynamics simulations was also studied.
A new series of pyrazoline-amide linked 1,2,3-triazole hybrids was wisely designed and synthesized using 1,3-dipolar cycloaddition between pyrazoline linked alkynes and 2-bromo-N-arylacetamide. All the newly synthesized compounds were evaluated in vitro against different microbial strains viz. Escherichia coli, Bacillius subtilis, Staphylococcus aureus, Aspergillus niger, and Candida albicans. Pyrazoline linked terminal alkynes (4a–c) showed MIC = 0.062–0.078 μmol/mL against different bacterial and fungal strain. However, pyrazoline-amide linked 1,2,3-triazole hybrids (6a-6t) showed MIC = 0.0229–0.050 μmol/mL. Compound 6e exhibited better efficacy against E. coli and both the fungal strains compared to standard drugs used. Docking studies of the most potent compounds were carried out against bacterial DNA Gyr A and fungal 14α-steroldemethylase were also performed. The binding potential of 4a and 6e with both the target using molecular dynamics simulations was also investigated.
[Display omitted]</description><identifier>ISSN: 0022-2860</identifier><identifier>EISSN: 1872-8014</identifier><identifier>DOI: 10.1016/j.molstruc.2021.131154</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Amide ; Antimicrobial agent ; Crystal structure ; Docking studies ; Pyrazoline ; Triazole</subject><ispartof>Journal of molecular structure, 2021-12, Vol.1246, p.131154, Article 131154</ispartof><rights>2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133</citedby><cites>FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kumar, Lokesh</creatorcontrib><creatorcontrib>Lal, Kashmiri</creatorcontrib><creatorcontrib>Kumar, Ashwani</creatorcontrib><creatorcontrib>Paul, Avijit Kumar</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><title>Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies</title><title>Journal of molecular structure</title><description>•New series of pyrazoline-amide linked 1,2,3-triazole hybrids was synthesized.•Pyrazoline-amide linked 1,2,3-triazole hybrid exhibited better antimicrobial activity compared to their precursors.•Docking studies were performed with E. coli Gyr A and A. Niger 14-α-demethylase.•The binding potential of 6e with both the target using molecular dynamics simulations was also studied.
A new series of pyrazoline-amide linked 1,2,3-triazole hybrids was wisely designed and synthesized using 1,3-dipolar cycloaddition between pyrazoline linked alkynes and 2-bromo-N-arylacetamide. All the newly synthesized compounds were evaluated in vitro against different microbial strains viz. Escherichia coli, Bacillius subtilis, Staphylococcus aureus, Aspergillus niger, and Candida albicans. Pyrazoline linked terminal alkynes (4a–c) showed MIC = 0.062–0.078 μmol/mL against different bacterial and fungal strain. However, pyrazoline-amide linked 1,2,3-triazole hybrids (6a-6t) showed MIC = 0.0229–0.050 μmol/mL. Compound 6e exhibited better efficacy against E. coli and both the fungal strains compared to standard drugs used. Docking studies of the most potent compounds were carried out against bacterial DNA Gyr A and fungal 14α-steroldemethylase were also performed. The binding potential of 4a and 6e with both the target using molecular dynamics simulations was also investigated.
[Display omitted]</description><subject>Amide</subject><subject>Antimicrobial agent</subject><subject>Crystal structure</subject><subject>Docking studies</subject><subject>Pyrazoline</subject><subject>Triazole</subject><issn>0022-2860</issn><issn>1872-8014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkM1KAzEUhYMoWKuvIHmAznhzk5lJXSnFPygoqFtDmqR4y3RGkrRQn94p1bWrs_g4h8PH2KWAUoCor1blum9TjhtXIqAohRSiUkdsJHSDhQahjtkIALFAXcMpO0tpBQBiKI_Yx8su2u--pS7wHPJniMFzMcGJLHKkPQnpmr_uugElShNuu0xrcrFfkG152Np2YzP13QA8p44nasn1POWNp5DO2cnStilc_OaYvd_fvc0ei_nzw9Psdl44KTAXONVQY-N8rVAG3yiFta5Ao27kFHABEpdCYeV17UEvg1ausg5BNVbgQkg5ZvVhdziWUgxL8xVpbePOCDB7S2Zl_iyZvSVzsDQUbw7FMLzbUogmOQqdC55icNn4nv6b-AEM33Oz</recordid><startdate>20211215</startdate><enddate>20211215</enddate><creator>Kumar, Lokesh</creator><creator>Lal, Kashmiri</creator><creator>Kumar, Ashwani</creator><creator>Paul, Avijit Kumar</creator><creator>Kumar, Anil</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20211215</creationdate><title>Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies</title><author>Kumar, Lokesh ; Lal, Kashmiri ; Kumar, Ashwani ; Paul, Avijit Kumar ; Kumar, Anil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amide</topic><topic>Antimicrobial agent</topic><topic>Crystal structure</topic><topic>Docking studies</topic><topic>Pyrazoline</topic><topic>Triazole</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Lokesh</creatorcontrib><creatorcontrib>Lal, Kashmiri</creatorcontrib><creatorcontrib>Kumar, Ashwani</creatorcontrib><creatorcontrib>Paul, Avijit Kumar</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of molecular structure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Lokesh</au><au>Lal, Kashmiri</au><au>Kumar, Ashwani</au><au>Paul, Avijit Kumar</au><au>Kumar, Anil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies</atitle><jtitle>Journal of molecular structure</jtitle><date>2021-12-15</date><risdate>2021</risdate><volume>1246</volume><spage>131154</spage><pages>131154-</pages><artnum>131154</artnum><issn>0022-2860</issn><eissn>1872-8014</eissn><abstract>•New series of pyrazoline-amide linked 1,2,3-triazole hybrids was synthesized.•Pyrazoline-amide linked 1,2,3-triazole hybrid exhibited better antimicrobial activity compared to their precursors.•Docking studies were performed with E. coli Gyr A and A. Niger 14-α-demethylase.•The binding potential of 6e with both the target using molecular dynamics simulations was also studied.
A new series of pyrazoline-amide linked 1,2,3-triazole hybrids was wisely designed and synthesized using 1,3-dipolar cycloaddition between pyrazoline linked alkynes and 2-bromo-N-arylacetamide. All the newly synthesized compounds were evaluated in vitro against different microbial strains viz. Escherichia coli, Bacillius subtilis, Staphylococcus aureus, Aspergillus niger, and Candida albicans. Pyrazoline linked terminal alkynes (4a–c) showed MIC = 0.062–0.078 μmol/mL against different bacterial and fungal strain. However, pyrazoline-amide linked 1,2,3-triazole hybrids (6a-6t) showed MIC = 0.0229–0.050 μmol/mL. Compound 6e exhibited better efficacy against E. coli and both the fungal strains compared to standard drugs used. Docking studies of the most potent compounds were carried out against bacterial DNA Gyr A and fungal 14α-steroldemethylase were also performed. The binding potential of 4a and 6e with both the target using molecular dynamics simulations was also investigated.
[Display omitted]</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.molstruc.2021.131154</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2860 |
ispartof | Journal of molecular structure, 2021-12, Vol.1246, p.131154, Article 131154 |
issn | 0022-2860 1872-8014 |
language | eng |
recordid | cdi_crossref_primary_10_1016_j_molstruc_2021_131154 |
source | ScienceDirect Freedom Collection |
subjects | Amide Antimicrobial agent Crystal structure Docking studies Pyrazoline Triazole |
title | Pyrazoline tethered 1,2,3-triazoles: Synthesis, antimicrobial evaluation and in silico studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A47%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pyrazoline%20tethered%201,2,3-triazoles:%20Synthesis,%20antimicrobial%20evaluation%20and%20in%20silico%20studies&rft.jtitle=Journal%20of%20molecular%20structure&rft.au=Kumar,%20Lokesh&rft.date=2021-12-15&rft.volume=1246&rft.spage=131154&rft.pages=131154-&rft.artnum=131154&rft.issn=0022-2860&rft.eissn=1872-8014&rft_id=info:doi/10.1016/j.molstruc.2021.131154&rft_dat=%3Celsevier_cross%3ES0022286021012849%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c312t-2980627cd6423ed7442685082873902b032f1425d86d08fe84c5ac2047a12b133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |